In a remarkable feat of advanced surgical care, the hospital in Kolkata has successfully performed a 10-hour-long, high-risk surgery on a 60-year-old patient diagnosed with severely advanced ovarian ...

Patients with stage IV ovarian cancer can derive long-term benefits from neoadjuvant pembrolizumab and chemotherapy if they achieve a major pathologic response, according to research published in ...

An expert discusses how different adverse event profiles of antibody-drug conjugates (ADCs) influence treatment decisions by requiring careful patient selection based on comorbidities like prior lung ...

An expert discusses how clinicians and institutions can streamline biomarker-driven therapy decisions by establishing rapid turnaround times for biopsies and pathology results, maintaining in-house ...

Research led by Memorial Sloan Kettering Cancer Center (MSK) is shedding new light on how ovarian cancer evolves - insights ...

When Gibson died on Monday, at age 49, those closest to the poet consoled mourning fans by sharing some of Gibson’s last ...

A study published by Caris showed that certain tumor types had very low or no HER2 overexpression, which has implications for biomarker testing strategies.

Research led by Memorial Sloan Kettering Cancer Center (MSK) is shedding new light on how ovarian cancer evolves—insights ...

Verastem's FDA approval for KRAS-mutant LGSOC, strong pipeline, and catalysts signal growth potential. Click here to read an ...

Andrea Gibson, a celebrated poet and performance artist who through their verse explored gender identity, politics and their ...

A video reading of the poem, titled "Love Letter From the Afterlife" went viral after Gibson's passing was announced -- with ...

With a $1.2 million grant from the Department of Defense, a University of Houston engineer will lead a team of researchers in finding early markers for ovarian cancer.